Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Major Depressive Disorder Topic Center

woman looking down on phone
News
MDD Prevalence Tripled in Female Huntington Disease Patients
05/07/2024
Jolynn Tumolo
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major...
05/07/2024
Psych Congress Network
FDA approval stamp
News
FDA Approves First Prescription Digital Therapeutic for Adjunctive Major Depressive Disorder Treatment
04/30/2024
Meagan Thistle
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as...
04/30/2024
Psych Congress Network
quiz
Quiz
Age-Response Connection in Multilocus Sequential rTMS Therapy for Tinnitus With Comorbid Mental Health Conditions
03/18/2024
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study,...
03/18/2024
Psych Congress Network
Tinnitus
News
Multilocus Sequential rTMS Shows Promise in Treating Tinnitus, Especially in Absence of Comorbid Depression
03/06/2024
Meagan Thistle
Multilocus rTMS reduced tinnitus symptom severity in both patients with and without comorbid MDD in a recent open-label treatment study.
Multilocus rTMS reduced tinnitus symptom severity in both patients with and without comorbid MDD in a recent open-label treatment study.
Multilocus rTMS reduced tinnitus...
03/06/2024
Psych Congress Network
Study Reveals Significant Cognitive Impairment in Patients With MDD
News
Study Reveals Significant Cognitive Impairment in Patients With MDD
01/31/2024
Meagan Thistle
Individuals with major depressive disorder may have significant moderate cognitive deficits in executive function, memory, and attention, when compared to healthy subjects. Researchers published their findings in Psychotherapy and...
Individuals with major depressive disorder may have significant moderate cognitive deficits in executive function, memory, and attention, when compared to healthy subjects. Researchers published their findings in Psychotherapy and...
Individuals with major...
01/31/2024
Psych Congress Network
Rakesh Jain at Psych Congress Regionals
News
Novel Depression Treatments Focus of Psych Congress Regionals Q&A Session
01/04/2024
Meagan Thistle
Drs Jain and Mattingly answered audience questions regarding GABA and glutamate modulation in understanding and treating the psychological impact of TBI in the frontal lobe, and newer, flexible depression treatment options.
Drs Jain and Mattingly answered audience questions regarding GABA and glutamate modulation in understanding and treating the psychological impact of TBI in the frontal lobe, and newer, flexible depression treatment options.
Drs Jain and Mattingly answered...
01/04/2024
Psych Congress Network
How long must symptoms be present in order to diagnose MDD?
Quiz
How long must symptoms be present in order to diagnose MDD?
12/13/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
12/13/2023
Psych Congress Network
brain and pills
News
Esketamine Nasal Spray Combination Therapy Outperforms Quetiapine in TRD Treatment
12/07/2023
Meagan Thistle
The combination of esketamine nasal spray plus an SSRI or an SNRI has emerged as a superior treatment option for TRD, compared to extended-release quetiapine plus an SSRI or SNRI.
The combination of esketamine nasal spray plus an SSRI or an SNRI has emerged as a superior treatment option for TRD, compared to extended-release quetiapine plus an SSRI or SNRI.
The combination of esketamine...
12/07/2023
Psych Congress Network
pills
News
EEG May Predict Antidepressant Response, Tailoring Treatment for Patients
11/14/2023
Meagan Thistle
Electroencephalography (EEG) may help match patients with the optimal depression treatment for their unique needs by predicting response to specific antidepressant medications, according to recent research published in JAMA Network...
Electroencephalography (EEG) may help match patients with the optimal depression treatment for their unique needs by predicting response to specific antidepressant medications, according to recent research published in JAMA Network...
Electroencephalography (EEG) may...
11/14/2023
Psych Congress Network
pop quiz
Quiz
Which sleep disturbance is most strongly predictive of MDD recurrence?
11/07/2023
11/07/2023
Psych Congress Network
stock depression
Conference Poster Highlight
Sleep Disturbances Associated With MDD Recurrence Over 3 Years
10/31/2023
Jolynn Tumolo
Hypersomnolence, insomnia, and sleep dissatisfaction predicted the recurrence of MDD over 3 years, according to a poster presentation at Psych Congress.
Hypersomnolence, insomnia, and sleep dissatisfaction predicted the recurrence of MDD over 3 years, according to a poster presentation at Psych Congress.
Hypersomnolence, insomnia, and...
10/31/2023
Psych Congress Network

News Articles

woman looking down on phone
News
MDD Prevalence Tripled in Female Huntington Disease Patients
05/07/2024
Jolynn Tumolo
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major...
05/07/2024
Psych Congress Network
FDA approval stamp
News
FDA Approves First Prescription Digital Therapeutic for Adjunctive Major Depressive Disorder Treatment
04/30/2024
Meagan Thistle
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as...
04/30/2024
Psych Congress Network
Tinnitus
News
Multilocus Sequential rTMS Shows Promise in Treating Tinnitus, Especially in Absence of Comorbid Depression
03/06/2024
Meagan Thistle
Multilocus rTMS reduced tinnitus symptom severity in both patients with and without comorbid MDD in a recent open-label treatment study.
Multilocus rTMS reduced tinnitus symptom severity in both patients with and without comorbid MDD in a recent open-label treatment study.
Multilocus rTMS reduced tinnitus...
03/06/2024
Psych Congress Network
Study Reveals Significant Cognitive Impairment in Patients With MDD
News
Study Reveals Significant Cognitive Impairment in Patients With MDD
01/31/2024
Meagan Thistle
Individuals with major depressive disorder may have significant moderate cognitive deficits in executive function, memory, and attention, when compared to healthy subjects. Researchers published their findings in Psychotherapy and...
Individuals with major depressive disorder may have significant moderate cognitive deficits in executive function, memory, and attention, when compared to healthy subjects. Researchers published their findings in Psychotherapy and...
Individuals with major...
01/31/2024
Psych Congress Network
Rakesh Jain at Psych Congress Regionals
News
Novel Depression Treatments Focus of Psych Congress Regionals Q&A Session
01/04/2024
Meagan Thistle
Drs Jain and Mattingly answered audience questions regarding GABA and glutamate modulation in understanding and treating the psychological impact of TBI in the frontal lobe, and newer, flexible depression treatment options.
Drs Jain and Mattingly answered audience questions regarding GABA and glutamate modulation in understanding and treating the psychological impact of TBI in the frontal lobe, and newer, flexible depression treatment options.
Drs Jain and Mattingly answered...
01/04/2024
Psych Congress Network
brain and pills
News
Esketamine Nasal Spray Combination Therapy Outperforms Quetiapine in TRD Treatment
12/07/2023
Meagan Thistle
The combination of esketamine nasal spray plus an SSRI or an SNRI has emerged as a superior treatment option for TRD, compared to extended-release quetiapine plus an SSRI or SNRI.
The combination of esketamine nasal spray plus an SSRI or an SNRI has emerged as a superior treatment option for TRD, compared to extended-release quetiapine plus an SSRI or SNRI.
The combination of esketamine...
12/07/2023
Psych Congress Network
pills
News
EEG May Predict Antidepressant Response, Tailoring Treatment for Patients
11/14/2023
Meagan Thistle
Electroencephalography (EEG) may help match patients with the optimal depression treatment for their unique needs by predicting response to specific antidepressant medications, according to recent research published in JAMA Network...
Electroencephalography (EEG) may help match patients with the optimal depression treatment for their unique needs by predicting response to specific antidepressant medications, according to recent research published in JAMA Network...
Electroencephalography (EEG) may...
11/14/2023
Psych Congress Network
stock depression
Conference Poster Highlight
Sleep Disturbances Associated With MDD Recurrence Over 3 Years
10/31/2023
Jolynn Tumolo
Hypersomnolence, insomnia, and sleep dissatisfaction predicted the recurrence of MDD over 3 years, according to a poster presentation at Psych Congress.
Hypersomnolence, insomnia, and sleep dissatisfaction predicted the recurrence of MDD over 3 years, according to a poster presentation at Psych Congress.
Hypersomnolence, insomnia, and...
10/31/2023
Psych Congress Network
depression stock photo
Psych Congress Poster Brief
MDD Symptom Improvements With Zuranolone Extend to Daily Lives, Responders Report
10/10/2023
Jolynn Tumolo
Patients with MDD who responded to treatment with zuranolone said they experienced rapid improvement in depressive symptoms and in their daily lives, Psych Congress poster states.
Patients with MDD who responded to treatment with zuranolone said they experienced rapid improvement in depressive symptoms and in their daily lives, Psych Congress poster states.
Patients with MDD who responded...
10/10/2023
Psych Congress Network
stock mood disorder image
News
Novel Esketamine Treatment Shows Promise in Managing Fluctuating Antidepressant Response
10/01/2023
Meagan Thistle
A recent pilot randomized clinical trial found that esketamine may be an effective, safe treatment for fluctuating antidepressant response in patients with MDD.
A recent pilot randomized clinical trial found that esketamine may be an effective, safe treatment for fluctuating antidepressant response in patients with MDD.
A recent pilot randomized...
10/01/2023
Psych Congress Network
A young Black boy sits on the floor of a living room holding a video game controller and concentrated on his game
News
Virtual Gaming May Enhance Working Memory for Youth With ADHD
05/17/2024
Brionna Mendoza
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
A literature review presented...
05/17/2024
Psych Congress Network
News
One Year After ‘X Waiver’ Axing, Few New Patients Prescribed Meds for OUD
05/15/2024
Brionna Mendoza
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of...
05/15/2024
Psych Congress Network
ketamine brain image
News
Study Findings Support Esketamine and Psilocybin as Effective TRD Treatments
05/14/2024
Meagan Thistle
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and...
05/14/2024
Psych Congress Network
A depressed teen rides the bus and looks at a smartphone in their hand
News
Adolescents May Not Reliably Signal Self-Harm Risk on PHQ in Primary Care Screenings
05/13/2024
Jolynn Tumolo
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were...
05/13/2024
Psych Congress Network
TD Has ‘Severe Impact’ on Patients and Caregivers
News
TD Has ‘Severe Impact’ on Patients and Caregivers
05/10/2024
Evi Arthur
Tardive dyskinesia (TD) was found to have a “severe impact” on the lives of both patients and their caregivers across physical, psychological, and social domains. Results from the survey-based study were published in the Journal of Patient...
Tardive dyskinesia (TD) was found to have a “severe impact” on the lives of both patients and their caregivers across physical, psychological, and social domains. Results from the survey-based study were published in the Journal of Patient...
Tardive dyskinesia (TD) was...
05/10/2024
Psych Congress Network
Stimulant Use May Increase Heart Damage Risk in Young Adults With ADHD
News
Stimulant Use May Increase Heart Damage Risk in Young Adults With ADHD
05/07/2024
Evi Arthur
Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology. 
Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology. 
Stimulant use for...
05/07/2024
Psych Congress Network
woman looking down on phone
News
MDD Prevalence Tripled in Female Huntington Disease Patients
05/07/2024
Jolynn Tumolo
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major...
05/07/2024
Psych Congress Network
brain imaging
News
Overlooked Concussion in Children May Cause Mental Health Comorbidities
05/02/2024
Meagan Thistle
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant...
05/02/2024
Psych Congress Network
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
News
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
05/01/2024
Evi Arthur
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of...
05/01/2024
Psych Congress Network
FDA approval stamp
News
FDA Approves First Prescription Digital Therapeutic for Adjunctive Major Depressive Disorder Treatment
04/30/2024
Meagan Thistle
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as...
04/30/2024
Psych Congress Network

Interactive Features

quiz
Quiz
Age-Response Connection in Multilocus Sequential rTMS Therapy for Tinnitus With Comorbid Mental Health Conditions
03/18/2024
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study,...
03/18/2024
Psych Congress Network
How long must symptoms be present in order to diagnose MDD?
Quiz
How long must symptoms be present in order to diagnose MDD?
12/13/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
12/13/2023
Psych Congress Network
pop quiz
Quiz
Which sleep disturbance is most strongly predictive of MDD recurrence?
11/07/2023
11/07/2023
Psych Congress Network
Quiz illustration
Quiz
Can esketamine help manage fluctuating antidepressant response?
10/13/2023
Test your clinical knowledge with this quick quiz!
Test your clinical knowledge with this quick quiz!
Test your clinical knowledge...
10/13/2023
Psych Congress Network
What do patients consider as remission from MDD?
Quiz
What do patients consider as remission from MDD?
07/22/2023

Featuring Mark Zimmerman, MD

Featuring Mark Zimmerman, MD
Do you remember this interview with Dr Zimmerman?
Do you remember this interview with Dr Zimmerman?
Do you remember this interview...
07/22/2023
Psych Congress Network
quiz
Quiz
How many symptoms must be present to make an MDD diagnosis?
03/09/2023
Do you know how many diagnostic criteria symptoms must be present to make an MDD diagnosis? Take the quiz to find out!
Do you know how many diagnostic criteria symptoms must be present to make an MDD diagnosis? Take the quiz to find out!
Do you know how many diagnostic...
03/09/2023
Psych Congress Network
Pencils spell out quiz.
Quiz
How does MDD treatment change patients' brains?
01/13/2023
Take a quick quiz to test your clinical knowledge!
Take a quick quiz to test your clinical knowledge!
Take a quick quiz to test your...
01/13/2023
Psych Congress Network
Which 4 antidepressants found to be most effective and tolerable?
Quiz
Which 4 antidepressants found to be most effective and tolerable?
12/26/2022
End the year with another correct quiz question!
End the year with another correct quiz question!
End the year with another...
12/26/2022
Psych Congress Network
Quiz
How does walking affect MDD symptoms?
12/08/2022
Time for a quiz!
Time for a quiz!
Time for a quiz!
12/08/2022
Psych Congress Network
Can walking ease symptoms of MDD?
Quiz
Which disorders are genetically linked to MDD?
11/10/2022
Test your knowledge!
Test your knowledge!
Test your knowledge!
11/10/2022
Psych Congress Network
Pencils spell out quiz on their erasers
Quiz
Which tech challenges can telehealth providers expect to encounter most often?
05/14/2024
Hone your telepsychiatry skills with this quiz!
Hone your telepsychiatry skills with this quiz!
Hone your telepsychiatry skills...
05/14/2024
Psych Congress Network
Does in utero stimulant use increase risk of childhood neurodevelopmental disorders?
Quiz
Does in utero stimulant exposure increase risk of childhood neurodevelopmental disorders?
05/12/2024
Test your knowledge!
Test your knowledge!
Test your knowledge!
05/12/2024
Psych Congress Network
Why can bipolar disorder often be misdiagnosed as MDD?
Expert Insights Quiz
Why is bipolar disorder often misdiagnosed as MDD?
05/10/2024
Do you remember this Q&A with Dr Roger McIntyre?
Do you remember this Q&A with Dr Roger McIntyre?
Do you remember this Q&A with Dr...
05/10/2024
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy.
Quiz
Pediatric ADHD and Schizophrenia Risk
05/01/2024
Test your psychiatry knowledge with this quiz!
Test your psychiatry knowledge with this quiz!
Test your psychiatry knowledge...
05/01/2024
Psych Congress Network
FDA
Quiz
What were the FDA's preliminary findings after investigating GLP-1 RAs?
04/25/2024
Do you remember this FDA update?
Do you remember this FDA update?
Do you remember this FDA update?
04/25/2024
Psych Congress Network
Quiz
For TD, the APA recommends performing an assessment with a structured instrument how often?
04/18/2024
When treating tardive dyskinesia (TD), the American Psychiatric Association (APA) recommends performing an assessment with a structured instrument (e.g., AIMS, DISCUS) how often?
When treating tardive dyskinesia (TD), the American Psychiatric Association (APA) recommends performing an assessment with a structured instrument (e.g., AIMS, DISCUS) how often?
When treating tardive dyskinesia...
04/18/2024
Psych Congress Network
PCN quiz
Quiz
For TD, the APA recommends performing an assessment with a structured instrument how often?
04/18/2024
When treating tardive dyskinesia (TD), the American Psychiatric Association (APA) recommends performing an assessment with a structured instrument (e.g., AIMS, DISCUS) how often?
When treating tardive dyskinesia (TD), the American Psychiatric Association (APA) recommends performing an assessment with a structured instrument (e.g., AIMS, DISCUS) how often?
When treating tardive dyskinesia...
04/18/2024
Psych Congress Network
Women with ADHD are diagnosed how many years after men?
Quiz
Women with ADHD are diagnosed how many years after men?
04/17/2024
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
04/17/2024
Psych Congress Network
In an illustrated cartoon style, a man sits on the ground with his head in his hands
Quiz
Global Schizophrenia Care Rates
04/15/2024
Put your knowledge to the test with this quick quiz!
Put your knowledge to the test with this quick quiz!
Put your knowledge to the test...
04/15/2024
Psych Congress Network
Do men or women have an earlier age at onset of OCD?
Quiz
Do men or women have an earlier age at onset of OCD?
03/22/2024
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your...
03/22/2024
Psych Congress Network

Perspectives

Dr Jain
Videos
Which Antidepressant is the Right One for Medication Augmentation? A Journal Review With Rakesh Jain, MD
03/07/2022
Rakesh Jain, MD, MPH, discusses the question: When augmenting an antidepressant with another antidepressant, which one should I choose?
Rakesh Jain, MD, MPH, discusses the question: When augmenting an antidepressant with another antidepressant, which one should I choose?
Rakesh Jain, MD, MPH, discusses...
03/07/2022
Psych Congress Network
Craig Chepke
Videos
Identifying and Treating the Many Forms of Depression
02/15/2022
Craig Chepke, MD, FAPA, discusses the many forms of depression and shares his insights on diagnosis and treatment options.
Craig Chepke, MD, FAPA, discusses the many forms of depression and shares his insights on diagnosis and treatment options.
Craig Chepke, MD, FAPA,...
02/15/2022
Psych Congress Network
major depressive disorder
Blog
The Best and Worst Changes Brought On By the Pandemic
01/31/2022
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy...
01/31/2022
Psych Congress Network
Dr Bill Wilson
Blog
A Closer Look at Diagnosing Grief vs Depression
01/13/2022
William Wilson, MD, discusses how to identify grief vs depression.
William Wilson, MD, discusses how to identify grief vs depression.
William Wilson, MD, discusses...
01/13/2022
Psych Congress Network
rakesh jain
Videos
Rakesh Reviews: Predictors of Diagnostic Transition From Major Depressive Disorder to Bipolar Disorder: A Retrospective Observational Network Study
01/10/2022
Introducing the new journal club hosted by Rakesh Jain, MD, MPH. During this review, Dr Jain reviews an article from Translational Psychiatry.
Introducing the new journal club hosted by Rakesh Jain, MD, MPH. During this review, Dr Jain reviews an article from Translational Psychiatry.
Introducing the new journal club...
01/10/2022
Psych Congress Network
Understanding Cognition in Patients With MDD
Videos
Understanding Cognition in Patients With MDD
09/29/2020
Bernhard T. Baune, PhD, MD, head of the Department of Mental Health at the University of Münster, Germany, discusses the research needed to improve clinicians' understanding of cognition in patients with major depressive disorder.
Bernhard T. Baune, PhD, MD, head of the Department of Mental Health at the University of Münster, Germany, discusses the research needed to improve clinicians' understanding of cognition in patients with major depressive disorder.
Bernhard T. Baune, PhD, MD, head...
09/29/2020
Psych Congress Network
Improving Cognitive Function in Patients With MDD
Videos
Improving Cognitive Function in Patients With MDD
09/21/2020
Bernhard T. Baune, PhD, MD, of the University of Münster, Germany, discusses pharmacological treatments that may improve cognition in patients with major depressive disorder.
Bernhard T. Baune, PhD, MD, of the University of Münster, Germany, discusses pharmacological treatments that may improve cognition in patients with major depressive disorder.
Bernhard T. Baune, PhD, MD, of...
09/21/2020
Psych Congress Network
Podcasts
Depression: An Evolutionary Perspective With Charles Raison, MD
06/25/2020
Psych Congress Steering Committee member Charles Raison, MD, recently joined the Ottawa Institute of Cognitive Behavioural Therapy for an examination of depression through an evolutionary lens.
Psych Congress Steering Committee member Charles Raison, MD, recently joined the Ottawa Institute of Cognitive Behavioural Therapy for an examination of depression through an evolutionary lens.
Psych Congress Steering...
06/25/2020
Psych Congress Network
Combining Antidepressants When Treating Depression
Videos
Combining Antidepressants When Treating Depression
02/19/2020
Michael Thase, MD, provides details on the strategy of combining antidepressants when treating patients with depression.
Michael Thase, MD, provides details on the strategy of combining antidepressants when treating patients with depression.
Michael Thase, MD, provides...
02/19/2020
Psych Congress Network
Videos
Treatment Approaches for Patients With Depression and Substance Use Disorders
12/19/2019
W. Clay Jackson, MD, DipTh, of the University of Tennessee College of Medicine in Memphis, discusses treatment approaches for patients with depression and substance use disorders.
W. Clay Jackson, MD, DipTh, of the University of Tennessee College of Medicine in Memphis, discusses treatment approaches for patients with depression and substance use disorders.
W. Clay Jackson, MD, DipTh, of...
12/19/2019
Psych Congress Network
Kevin Williams, MS, MPAS, PA-C,
Videos
Unpacking the Patient Experience of Living With Tardive Dyskinesia
05/14/2024

Featuring Kevin Williams, MS, MPAS, PA-C

Featuring Kevin Williams, MS, MPAS, P...
Kevin Williams, MS, MPAS, PA-C, discusses the often-overlooked social and professional dimensions of life with tardive dyskinesia (TD).
Kevin Williams, MS, MPAS, PA-C, discusses the often-overlooked social and professional dimensions of life with tardive dyskinesia (TD).
Kevin Williams, MS, MPAS, PA-C, ...
05/14/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
Differentiating Between BPD and Bipolar Disorder in Clinical Practice
05/14/2024

With Rakesh Jain, MD, and Craig Chepke, MD

With Rakesh Jain, MD, and Craig Chepk...
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig...
05/14/2024
Psych Congress Network
Greg Mattingly, MD
Videos
The Future Role of Orexin Agonists for the Treatment of Narcolepsy, EDS, and Beyond
05/13/2024

Featuring Greg Mattingly, MD

Featuring Greg Mattingly, MD
Greg Mattingly, MD, explains how sleep can become disrupted and the novel solutions that the orexin receptor may make possible.
Greg Mattingly, MD, explains how sleep can become disrupted and the novel solutions that the orexin receptor may make possible.
Greg Mattingly, MD, explains how...
05/13/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
Managing Adverse Effects and Medication Changes in Bipolar Disorder
05/07/2024
In this podcast, Drs Craig Chepke and Rakesh Jain discuss switching medications and avoiding adverse effects like weight gain in bipolar disorder treatment.
In this podcast, Drs Craig Chepke and Rakesh Jain discuss switching medications and avoiding adverse effects like weight gain in bipolar disorder treatment.
In this podcast, Drs Craig...
05/07/2024
Psych Congress Network
Edward Kaftarian, MD.
Videos
Addressing Technological Challenges in Telehealth
05/03/2024

Featuring Edward Kaftarian, MD

Featuring Edward Kaftarian, MD ...
In this video, Edward Kaftarian, MD, offers some insight into common technical challenges that telehealth providers may encounter and how to proactively address them.
In this video, Edward Kaftarian, MD, offers some insight into common technical challenges that telehealth providers may encounter and how to proactively address them.
In this video, Edward Kaftarian,...
05/03/2024
Psych Congress Network
Desiree Matthews, PHMNP-BC
Videos
Medication Limitations and Adverse Effects in Bipolar Disorder Treatment
04/29/2024

Featuring Desiree Matthews, PMHNP-BC

Featuring Desiree Matthews, PMHNP-BC ...
Join Desiree Matthews, PHMNP-BC, as she explores the limitations of traditional antipsychotic agents and off-label therapies in bipolar disorder treatment.
Join Desiree Matthews, PHMNP-BC, as she explores the limitations of traditional antipsychotic agents and off-label therapies in bipolar disorder treatment.
Join Desiree Matthews, PHMNP-BC,...
04/29/2024
Psych Congress Network
Desiree Matthews, PHMNP-BC
Videos
Common Challenges for Clinicians Prescribing Antipsychotics
04/22/2024

Featuring Desiree Matthews, PHMNP-BC

Featuring Desiree Matthews, PHMNP-BC ...
Join Nurse Matthews for an in-depth exploration of the primary challenges faced by clinicians treating patients with bipolar disorder.
Join Nurse Matthews for an in-depth exploration of the primary challenges faced by clinicians treating patients with bipolar disorder.
Join Nurse Matthews for an...
04/22/2024
Psych Congress Network
Penn and Jain
Videos
Healing Health Care Burnout and Lessons Learned From the COVID-19 Pandemic
04/16/2024

Featuring Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP

Featuring Saundra Jain, MA, PsyD, LPC...
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP, unpack the profound and lasting impacts of burnout among health care professionals in the wake of the COVID-19 pandemic.
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP, unpack the profound and lasting impacts of burnout among health care professionals in the wake of the COVID-19 pandemic.
Saundra Jain, MA, PsyD, LPC, and...
04/16/2024
Psych Congress Network
Desiree Matthews, PMHNP-BC.
Videos
Tardive Dyskinesia: Impacts, Assessment, and Treatment Options
04/15/2024

Featuring Desiree Matthews, PMHNP-BC

Featuring Desiree Matthews, PMHNP-BC ...
Gain fresh insights into the multifaceted impacts of tardive dyskinesia (TD) with Desiree Matthews, PMHNP-BC, as she explores the physical, social, and emotional consequences faced by patients living with TD.
Gain fresh insights into the multifaceted impacts of tardive dyskinesia (TD) with Desiree Matthews, PMHNP-BC, as she explores the physical, social, and emotional consequences faced by patients living with TD.
Gain fresh insights into the...
04/15/2024
Psych Congress Network
Desiree Matthews, PMHNP-BC.
Videos
Tardive Dyskinesia: Impacts, Assessment, and Treatment Options
04/15/2024

Featuring Desiree Matthews, PMHNP-BC

Featuring Desiree Matthews, PMHNP-BC ...
Gain fresh insights into the multifaceted impacts of tardive dyskinesia (TD) with Desiree Matthews, PMHNP-BC, as she explores the physical, social, and emotional consequences faced by patients living with TD.
Gain fresh insights into the multifaceted impacts of tardive dyskinesia (TD) with Desiree Matthews, PMHNP-BC, as she explores the physical, social, and emotional consequences faced by patients living with TD.
Gain fresh insights into the...
04/15/2024
Psych Congress Network

Posters

Utilization of Psychiatric Pharmacogenomic Testing by Primary Care Physicians and Advanced Practice Providers: Confidence and Implementation Barriers
Routine implementation of pharmacogenomic testing for mental health and other conditions treated in primary care may require overcoming barriers such as cost to the patient and knowledge ...
10/26/2023
Valbenazine Improves Tardive Dyskinesia With or Without Concomitant Antipsychotic Therapy: A Meta-Analysis of Three Long-Term Valbenazine Trials
Valbenazine is indicated for once-daily treatment of tardive dyskinesia (TD), a movement disorder associated with prolonged antipsychotic exposure. Data from 3 long-term studies (KINECT™-...
10/26/2023
Veterans’ Intensive​ PCMHI Boot Camp​ (VIP Boot Camp)
Veterans Intensive Primary Care Mental Health Integration Bootcamp (VIP Bootcamp): An upstream solution to Mental Health(MH) access issues within the VA system
10/26/2023
Viloxazine ER (Qelbree®) Administered with Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Topline Results of a Phase IV Safety Trial
Results of a phase IV, open-label safety study evaluating viloxazine ER (Qelbree®) administered with psychostimulants in pediatric (6-17 years) ADHD; morning vs. evening administration of...
10/26/2023
Withdrawal Catatonia: A Rare Case of Treatment-Resistant Catatonia Secondary to Quetiapine Withdrawal
Catatonia is a psychomotor syndrome with well-defined clinical characteristics, although the neurological mechanisms involved remain unknown. In this study, we report a case of a patient ...
10/26/2023
Zuranolone Safety and Tolerability in Adults with Postpartum Depression: Analyses from SKYLARK, a 50 mg Placebo-Controlled Study
In the SKYLARK Study, zuranolone 50 mg was generally well tolerated in adults with postpartum depression; treatment-emergent adverse events (TEAEs) led to zuranolone dose reduction and di...
10/26/2023
Unique Features of the Rapid Mood Screener Enable Detection of Bipolar I Disorder in a Primary Care Practice
The Rapid Mood Screener (RMS) is a self-administered screening tool to help differentiate bipolar I disorder from major depressive disorder. Cases were identified from a primary care sett...
10/26/2023
Use Of VMAT2 Inhibitors For Tardive Dyskinesia In Geriatric Populations - A Case Study
This case report discusses the safety and efficacy of VMAT2 inhibitors in treating antipsychotic induced tardive dyskinesia in adults >55 years old. It also highlights the increased ri...
10/26/2023
Using Chess as a Novel Means to Cure Treatment Refractory Catatonia
The subject matter of the poster includes a case report of a patient with treatment refractory catatonia whose condition rapidly improved following a game of chess, one of the patient's k...
10/26/2023
Understanding the Real-World Prescription Patterns and Impact of Atypical Antipsychotic Augmentation Timing on Healthcare Cost in Adult Major Depressive Disorder in the United States: A Systematic Literature Review
This study examined the utilization pattern of augmentation with atypical antipsychotics after partial or no response to antidepressants in patients with MDD. The antidepressant prescript...
10/26/2023

Practice Tools

Saundra's Corner
Edinburgh Postnatal Depression Scale (EPDS)
09/30/2016
How to Use Proven to be an effective screening tool to identify patients at risk for “perinatal” depression Valuable, efficient and easy to administer  Mother asked to check the response that comes closest to how she has been...
How to Use Proven to be an effective screening tool to identify patients at risk for “perinatal” depression Valuable, efficient and easy to administer  Mother asked to check the response that comes closest to how she has been...
How to Use Proven to be...
09/30/2016
Psych Congress Network
Saundra's Corner
Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR-16)
09/30/2016
How to Use Quick Inventory of Depressive Symptomatology (Self-Report)  (QIDS-SR-16) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment. It is...
How to Use Quick Inventory of Depressive Symptomatology (Self-Report)  (QIDS-SR-16) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment. It is...
How to...
09/30/2016
Psych Congress Network
Saundra's Corner
Geriatric Depression Scale Short Form (GDS-SF)
09/29/2016
How to Use 15-item screening tool used to identify depression in older adults  Used with healthy, medically ill and mild to moderately cognitively impaired adults Extensively used in community, acute and long-term care...
How to Use 15-item screening tool used to identify depression in older adults  Used with healthy, medically ill and mild to moderately cognitively impaired adults Extensively used in community, acute and long-term care...
How to Use 15-item...
09/29/2016
Psych Congress Network
Saundra's Corner
Cornell Scale for Depression in Dementia (CSDD)
09/29/2016
How to Use The CSDD is designed to assess depression in elderly residents with dementia  Takes ~ 20 minutes to administer The ratings should be based on depressive symptoms and signs occurring during the week...
How to Use The CSDD is designed to assess depression in elderly residents with dementia  Takes ~ 20 minutes to administer The ratings should be based on depressive symptoms and signs occurring during the week...
How to Use The CSDD is...
09/29/2016
Psych Congress Network
Saundra's Corner
Hamilton Depression Rating Scale (HAM-D)
09/29/2016
  Click here for the HAM-D How to Use The Hamilton Depression Rating Scale (HAM-D) has proven useful for many years as a way of determining a patient’s level...
  Click here for the HAM-D How to Use The Hamilton Depression Rating Scale (HAM-D) has proven useful for many years as a way of determining a patient’s level...
...
09/29/2016
Psych Congress Network
Saundra's Corner
Medication Adherence Rating Scale (MARS)
01/29/2019
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for...
01/29/2019
Psych Congress Network
Saundra's Corner
Sheehan Disability Scale (SDS)
01/28/2019
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS...
01/28/2019
Psych Congress Network
Saundra's Corner
Brief Psychiatric Rating Scale (BPRS)
01/28/2019
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
...
01/28/2019
Psych Congress Network
Saundra's Corner
The Mini International Neuropsychiatric Interview
01/28/2019
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is...
01/28/2019
Psych Congress Network
Saundra's Corner
MINI Screen
01/28/2019
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen...
01/28/2019
Psych Congress Network
Saundra's Corner
Patient Health Questionnaire (PHQ-9)
01/28/2019
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health...
01/28/2019
Psych Congress Network
Saundra's Corner
WHO (Five) Well-Being Index (WHO-5)
01/28/2019
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated...
01/28/2019
Psych Congress Network
Saundra's Corner
Beck Depression Inventory-II (BDI-II)
01/28/2019
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to...
01/28/2019
Psych Congress Network
Saundra's Corner
Mood Disorder Questionnaire (MDQ)
01/28/2019
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder...
01/28/2019
Psych Congress Network
Saundra's Corner
Hamilton Anxiety Rating Scale (HAM-A)
01/28/2019
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
...
01/28/2019
Psych Congress Network

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Recent Stories

woman looking down on phone
News
MDD Prevalence Tripled in Female Huntington Disease Patients
05/07/2024
Jolynn Tumolo
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major...
05/07/2024
Psych Congress Network
FDA approval stamp
News
FDA Approves First Prescription Digital Therapeutic for Adjunctive Major Depressive Disorder Treatment
04/30/2024
Meagan Thistle
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as...
04/30/2024
Psych Congress Network
quiz
Quiz
Age-Response Connection in Multilocus Sequential rTMS Therapy for Tinnitus With Comorbid Mental Health Conditions
03/18/2024
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study,...
03/18/2024
Psych Congress Network
Tinnitus
News
Multilocus Sequential rTMS Shows Promise in Treating Tinnitus, Especially in Absence of Comorbid Depression
03/06/2024
Meagan Thistle
Multilocus rTMS reduced tinnitus symptom severity in both patients with and without comorbid MDD in a recent open-label treatment study.
Multilocus rTMS reduced tinnitus symptom severity in both patients with and without comorbid MDD in a recent open-label treatment study.
Multilocus rTMS reduced tinnitus...
03/06/2024
Psych Congress Network
Study Reveals Significant Cognitive Impairment in Patients With MDD
News
Study Reveals Significant Cognitive Impairment in Patients With MDD
01/31/2024
Meagan Thistle
Individuals with major depressive disorder may have significant moderate cognitive deficits in executive function, memory, and attention, when compared to healthy subjects. Researchers published their findings in Psychotherapy and...
Individuals with major depressive disorder may have significant moderate cognitive deficits in executive function, memory, and attention, when compared to healthy subjects. Researchers published their findings in Psychotherapy and...
Individuals with major...
01/31/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement